http://www.cyclacel.com
Cyclacel Pharmaceuticals, Inc. Company Intro
Cyclacel is a biopharmaceutical company, based in Berkeley Heights, New Jersey and Dundee, Scotland, that develops orally available small molecule drugs which target various cell cycle phases to control cancer and other serious diseases.
Industry
Healthcare
Cyclacel Pharmaceuticals, Inc. Headquaters
200 Connell Drive
Berkeley Heights,07922
United States
Cyclacel Pharmaceuticals, Inc. Share price
22 Jan 2021 01:28 GMT
$8.86
-0.15 (-1.66 %)
Cyclacel Pharmaceuticals, Inc. Market cap
$35.75 M
WMC RANKING
2021
Cyclacel Pharmaceuticals, Inc. # 308
BiotechnologyLatest Cyclacel Pharmaceuticals, Inc. News
21 Jan 2021
Comprehensive Report on Cyclin Dependent Kinase 7 Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | Aurigene Discovery Technologies Ltd, Beta Pharma Inc, Cyclacel Pharmaceuticals Inc, Qurient Co Ltd, Syros Pharmaceuticals Inc
... Forecast To 2027 | Aurigene Discovery Technologies Ltd, Beta Pharma Inc, Cyclacel Pharmaceuticals Inc, Qurient Co Ltd, Syros Pharmaceuticals Inc.
22 Jan 2021
Know about Cyclin Dependent Kinase 7 Market Influencing ...
... Discovery Technologies Ltd, Beta Pharma Inc, Cyclacel Pharmaceuticals Inc, ... The report highlights the company profiles, market share, regional outlook, ...
21 Jan 2021
Comprehensive Report on Cyclin Dependent Kinase 7 Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | Aurigene Discovery Technologies Ltd, Beta Pharma Inc, Cyclacel Pharmaceuticals Inc, Qurient Co Ltd, Syros Pharmaceuticals Inc
... Forecast To 2027 | Aurigene Discovery Technologies Ltd, Beta Pharma Inc, Cyclacel Pharmaceuticals Inc, Qurient Co Ltd, Syros Pharmaceuticals Inc.
WMC Market Score
WMC Market to Revenue Score
Cyclacel Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cyclacel Pharmaceuticals, Inc. | USD | $150 | $9,503 | $-7,744 | $358M | 308 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cyclacel Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cyclacel Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cyclacel Pharmaceuticals, Inc. | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
